The '80s were so different than 2026 in terms of technology, but there were a lot of great pieces that if they returned, ...
Celltrion said on the 24th that it received additional approval from the Ministery of Food and Drug Safety for the auto-injector (AI) formulation of the allergy disease treatment "OMLYCLO." The ...
The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and ...
Banco Bilbao Vizcaya Argentaria (BBVA) and Natixis have reached put option deals with a wholly owned subsidiary of Geely Sweden Holdings. Credit: Polestar. Swedish automotive manufacturer Polestar has ...
Novo and Lilly Cut Prices of Weight-Loss Drugs in China Dec 29 (Reuters) - Novo Nordisk and Eli Lilly are lowering prices of their top-selling obesity drugs Wegovy and Mounjaro in China, according ...
Dec 29 (Reuters) - Novo Nordisk and Eli Lilly are lowering prices of their top-selling obesity drugs Wegovy and Mounjaro in China, according to the Danish drugmaker and Chinese drug suppliers. Novo ...
Year after year, Mary Bucklew strategized with a nurse practitioner about losing weight. “We tried exercise,” like walking 35 minutes a day, she recalled. “And 39,000 different diets.” But 5 pounds ...
Novo Nordisk A/S launches oral Wegovy in the U.S. at aggressive introductory pricing, aiming to secure early market share and first-mover advantage. NVO faces imminent semaglutide patent expiry in ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Off the Scales: The Inside Story of Ozempic and the Race to Cure Obesity by Aimee Donnellan (4th Estate/St ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results